Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: AdSurf; ALEC; Artificial lung expanding compound; Zofac

Latest Information Update: 04 Aug 2010

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Britannia Pharmaceuticals
  • Class Phospholipids; Pulmonary surfactants
  • Mechanism of Action Cell membrane permeability enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Market Withdrawal Neonatal respiratory distress syndrome
  • No development reported Post-surgical adhesions
  • Discontinued Asthma; Respiratory tract disorders

Most Recent Events

  • 08 Sep 2009 Discontinued - Phase-II for Asthma in United Kingdom (Inhalation)
  • 08 Sep 2009 Discontinued - Preclinical for Respiratory tract disorders in United Kingdom (unspecified route)
  • 12 Nov 2004 Pumactant has been licensed to airPharma worldwide (except the UK and Ireland) for the treatment of asthma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top